stars 1 stars 2 stars 3

SynphaBase AG is a Swiss-based custom research and development organization (CRDO) specializing in medicinal chemistry, process R&D, and glycoscience, including high-purity carbohydrate synthesis. Established in 2000 and servicing pharma, biotech, fine chemicals, and academic sectors, the company offers integrated support from early-stage route scouting to GMP-grade manufacturing in partnership with CMOs. With over 2,000 completed projects (from milligram to multi‑kilogram, GMP & non‑GMP) as of ~2024, SynphaBase emphasizes process optimization, reproducibility, and structural precision tailored to complex molecule types. Innovation focuses heavily on oligosaccharides and carbohydrate-conjugates. Synphabase operate under an ISO9001:2015-certified quality management system and are authorized by Swissmedic to support GMP-compliant processes through qualified contract manufacturing partners (CMOs).

SynphaBase AG Questions

The SynphaBase AG annual revenue was $5.6 million in 2026.

Arthur Bodenmueller is the CEO of SynphaBase AG.

8 people are employed at SynphaBase AG.

SynphaBase AG is based in Pratteln, Basel-landschaft.

The NAICS codes for SynphaBase AG are [325, 32541, 32, 3254].

The SIC codes for SynphaBase AG are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users